Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-28T12:56:28.967Z Has data issue: false hasContentIssue false
  • English
  • Français

Sociodemographic characteristics associated with an eHealth system designed to reduce depressive symptoms among patients with breast or prostate cancer: a prospective study

Published online by Cambridge University Press:  01 September 2022

N.G. Petros ,
G. Hadlaczky ,
S. Carletto ,
S.G. Martínez ,
B. Meyer ,
L. Ostacoli ,
M. Ottaviano ,
E.P. Scilingo  and
V. Carli
N.G. Petros*
Affiliation:
Karolinska Institutet, Learning, Information, Management And Ethics, Stockholm, Sweden
G. Hadlaczky
Affiliation:
Karolinska Institutet, Learning, Information, Management And Ethics, Stockholm, Sweden
S. Carletto
Affiliation:
University of Torino, Department Of Neuroscience “rita Levi Montalcini”, Torino, Italy
S.G. Martínez
Affiliation:
Universidad Politécnica de Madrid, Life Supporting Technologies, Madrid, Spain
B. Meyer
Affiliation:
GAIA AG, Gaia Ag, Hamburg, Germany
L. Ostacoli
Affiliation:
University of Turin, Department Of Clinical And Biological Sciences, Turin, Italy
M. Ottaviano
Affiliation:
Universidad Politécnica de Madrid, Life Supporting Technologies, Madrid, Spain
E.P. Scilingo
Affiliation:
University of Pisa, Department Of Information Engineering, Pisa, Italy
V. Carli
Affiliation:
Karolinska Institutet, Learning, Information, Management And Ethics, Stockholm, Sweden
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Electronic health (eHealth) interventions integrate different elements of care in treating and preventing mental ill-health in patients with somatic illnesses. Identifying different sociodemographic characteristics that might be associated with higher perceived usability can help in improving the usability of these e-health interventions.

Objectives

This study aimed to identify sociodemographic characteristics that might be associated with the perceived usability of the NEVERMIND e-health system, comprised of a mobile application and a sensorized shirt, developed to reduce co-morbid depressive symptoms in patients with breast or prostate cancer.

Methods

The study included 129 patients with a diagnosis of breast or prostate cancer who received the NEVERMIND system. Sociodemographic data were collected at baseline. Usability outcomes included the System Usability Scale (SUS), the Mobile Application Rating Scale: user version (uMARS), and a usage index.

Results

The analysis was based on 108 patients (68 breast cancer and 40 prostate cancer patients) who used the NEVERMIND system. The overall mean SUS score at 12-weeks was 73.4 with no statistical differences among different sociodemographic characteristics. The global uMARS score was 3.8, and females scored the app higher than males (β coefficient= 0.16; p=.03, 95% CI 0.02 - 0.3). Females had significant lower usage (β coefficient= -0.13; p=.04, 95% CI -0.25 to -0.01) after adjusting for other covariates.

Conclusions

There was a higher favourability of the mobile application among females compared to males. However, males had significantly higher usage of the NEVERMIND system. The NEVERMIND system does not suffer from ‘digital divide’ where certain sociodemographic characteristics are more associated with higher usability.

Disclosure

No significant relationships.

Keywords

eHealthUsabilityDepressionmental health
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S170
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.